Search Results - Morozova, O.

System-level analysis of neuroblastoma tumor-initiating cells implicates AURKB as a novel drug target for neuroblastoma by Morozova, O., Vojvodic, M., Grinshtein, N., Hansford, L., Blakely, K., Maslova, A., Hirst, M., Cezard, T., Morin, R., Moore, R., Smith, K., Miller, F., Taylor, P., Thiessen, N., Varhol, Richard, Zhao, Y., Jones, S., Moffat, J., Kislinger, T., Moran, M., Kaplan, D., Marra, M.

Get full text

Concurrent CIC mutations, IDH mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancers by Yip, S., Butterfield, Y., Morozova, O., Chittaranjan, S., Blough, M., An, J., Birol, I., Chesnelong, C., Chiu, R., Chuah, E., Corbett, R., Docking, R., Firme, M., Hirst, M., Jackman, S., Karsan, A., Li, H., Louis, D., Maslova, A., Moore, R., Moradian, A., Mungall, K., Perizzolo, M., Qian, J., Roldan, G., Smith, E., Tamura-Wells, J., Thiessen, N., Varhol, Richard, Weiss, S., Wu, W., Young, S., Zhao, Y., Mungall, A., Jones, S., Morin, G., Chan, J., Cairncross, J., Marra, M.

Get full text